The proposed bill, titled the "Unregulated Intoxicating Consumer Products Control Act," aims to establish a regulatory framework in Montana that prohibits the preparation, distribution, sale, or offer for sale of unregulated psychoactive consumer products. The bill defines "psychoactive consumer products" and outlines specific exceptions, including FDA-approved drugs, prescription medications, and certain dietary supplements. It mandates that any psychoactive product must be authorized under state law and subject to regulatory oversight, thereby ensuring consumer safety and compliance with existing regulations.

Enforcement of the act will be managed by the Department of Revenue, which is granted authority to impose penalties for noncompliance, including cease-and-desist orders and civil fines. The bill also requires the department to collaborate with other state agencies to establish testing standards and identify products that may evade regulation. Additionally, the department is tasked with biennial reporting to legislative committees on enforcement actions and market trends related to psychoactive consumer products. The act is set to take effect on July 1, 2027, with certain provisions becoming effective immediately upon passage.